Skip to content

Cart

Your cart is empty

Continue shopping
Press & News · August 26, 2026

Amoena Applauds Bipartisan Members of Congress for Supporting Breast Cancer Survivors

Amoena proudly supports H.R. 10147, bipartisan legislation that would reclassify mastectomy bras as medical devices—making them more affordable and accessible for the millions of women who depend on them.

Amoena is proud to support H.R. 10147, introduced by U.S. Representatives Carol Miller (R-WV) and Terri Sewell (D-AL). This legislation would reclassify mastectomy bras as medical devices, rather than regular apparel, in the tariff code—a much more accurate description of the use of these products—amending the United States tariff schedule to establish proper tariff classifications for silicone breast prosthetics and mastectomy bras.

The Need for Reclassification

Breast cancer is the most commonly diagnosed cancer in women, with two million new cases worldwide each year. 70% of patients have breast-conserving surgery during the course of their treatment. For some breast cancer patients and survivors, particularly those who have endured high levels of radiation, reconstructive surgery is not medically recommended or possible.

Mastectomy bras are engineered to hold and support prosthetic breast forms, which aid in recovery, balance, and spinal alignment while mitigating the risk of long-term chronic pain.

Already Recognized as Medical Products Several federal agencies classify mastectomy bras as medical products, including TRICARE, the Food and Drug Administration, and the Centers for Medicare and Medicaid Services. Several private insurers and trading partners like Canada and Australia also consider mastectomy bras to be medical devices.

Amoena’s Statement

“Amoena is grateful to Representatives Carol Miller and Terri Sewell for their bipartisan leadership and commitment to supporting the millions of breast cancer survivors and women currently undergoing breast cancer treatment. Their legislation recognizes the essential role these medically necessary products play in post-mastectomy care and will help make them more affordable and accessible for the women who rely on them. We thank Representatives Miller and Sewell for recognizing these important health care needs and for working to ensure that women affected by breast cancer have access to the care and products they need throughout their recovery.” — Taimur Mehmood, Chief Executive Officer, Amoena USA

With 50 years of experience developing state-of-the-art products, working with small businesses and healthcare systems, and helping women find their safest and healthiest fit, Amoena stands ready to work with policymakers and stakeholders to support this legislation.

About Amoena

Amoena is the world’s leading manufacturer in the field of breast care and the developer of the first silicone breast prosthesis. With more than 50 years of experience, our goal is to combine the function of our breast forms with innovative, award-winning design and the highest level of comfort. Amoena breast prostheses are still manufactured by hand in Raubling, Germany.

Amoena’s latest innovation, the Adapt Air breast form, which features air chamber technology, received the Red Dot Design Award as well as four other international design and innovation awards. To support and empower women on their journey through breast cancer, the Amoena product portfolio of recovery care, breast forms and breast care apparel is designed to support women from diagnosis to their return to everyday life. Today, around 400 employees worldwide work toward this mission with full commitment and passion.

Amoena Mara breast form
Amoena’s innovative breast care products support women at every stage of their journey.

Learn More About Amoena

Discover our commitment to supporting women through every stage of breast cancer care—from diagnosis to recovery and beyond.

About Amoena Explore Breast Forms

HCP Newsletter

Signup to receive news and updated from amoena